Guanhao Biotech Co Ltd
Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products primarily in China. It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological … Read more
Guanhao Biotech Co Ltd (300238) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.027x
Based on the latest financial reports, Guanhao Biotech Co Ltd (300238) has a cash flow conversion efficiency ratio of 0.027x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.36 Million) by net assets (CN¥493.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guanhao Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Guanhao Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guanhao Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guanhao Biotech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Time Technoplast Limited
NSE:TIMETECHNO
|
0.087x |
|
Beijing Bayi Space LCD Technology Co Ltd
SHG:688181
|
0.057x |
|
Global Medical REIT Inc.
NYSE:GMRE
|
0.035x |
|
Baotou Huazi Industry Co Ltd
SHG:600191
|
0.016x |
|
CorMedix Inc
NASDAQ:CRMD
|
0.082x |
|
Guangzhou Guangri Stock Co Ltd
SHG:600894
|
0.014x |
|
i3 Verticals Inc
NASDAQ:IIIV
|
0.029x |
|
Flaircomm Microelectronics Inc Ordinary Shares - Class A
SHE:301600
|
N/A |
Annual Cash Flow Conversion Efficiency for Guanhao Biotech Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Guanhao Biotech Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥467.59 Million | CN¥49.55 Million | 0.106x | -10.70% |
| 2023-12-31 | CN¥456.26 Million | CN¥54.15 Million | 0.119x | -27.96% |
| 2022-12-31 | CN¥430.88 Million | CN¥70.98 Million | 0.165x | +0.70% |
| 2021-12-31 | CN¥748.16 Million | CN¥122.39 Million | 0.164x | +12.91% |
| 2020-12-31 | CN¥716.66 Million | CN¥103.84 Million | 0.145x | +10.24% |
| 2019-12-31 | CN¥704.14 Million | CN¥92.55 Million | 0.131x | +370.53% |
| 2018-12-31 | CN¥1.16 Billion | CN¥32.28 Million | 0.028x | +76.29% |
| 2017-12-31 | CN¥1.21 Billion | CN¥19.22 Million | 0.016x | -24.74% |
| 2016-12-31 | CN¥1.46 Billion | CN¥30.68 Million | 0.021x | -80.75% |
| 2015-12-31 | CN¥620.62 Million | CN¥67.87 Million | 0.109x | -11.18% |
| 2014-12-31 | CN¥531.61 Million | CN¥65.45 Million | 0.123x | +47.83% |
| 2013-12-31 | CN¥498.16 Million | CN¥41.49 Million | 0.083x | -23.01% |
| 2012-12-31 | CN¥454.11 Million | CN¥49.12 Million | 0.108x | +32.06% |
| 2011-12-31 | CN¥432.79 Million | CN¥35.45 Million | 0.082x | -64.81% |
| 2010-12-31 | CN¥144.99 Million | CN¥33.76 Million | 0.233x | +222.72% |
| 2009-12-31 | CN¥76.95 Million | CN¥5.55 Million | 0.072x | -44.41% |
| 2008-12-31 | CN¥37.01 Million | CN¥4.80 Million | 0.130x | +55.21% |
| 2007-12-31 | CN¥20.67 Million | CN¥1.73 Million | 0.084x | -- |